 Biotechnology company Evogene Ltd. NASDAQ: EVGN TASE: EVGN posted its financial results Wednesday for the first half and second quarter of 2021 along with a proclamation from the companys president and CEO Ofer Haviv in which he said that this fiscal year is turning out to be a key strategic year for unlocking value at Evogene and its subsidiaries. 